RVL Pharmaceuticals plc·4

Jan 26, 5:16 PM ET

Klein Christopher 4

4 · RVL Pharmaceuticals plc · Filed Jan 26, 2023

Insider Transaction Report

Form 4
Period: 2023-01-24
Klein Christopher
General Counsel and Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2023-01-24$1.26/sh9,608$12,106186,020 total

Documents

1 file
  • 4
    tm234531-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT